17 research outputs found
Identification and engineering of the cytochalasin gene cluster from Aspergillus clavatus NRRL 1
Cytochalasins are a group of fungal secondary metabolites with diverse structures and bioactivities, including cytochalasin E produced by Aspergillus clavatus, which is a potent anti-angiogenic agent. Here, we report the identification and characterization of the cytochalasin gene cluster from A. clavatus NRRL 1. As a producer of cytochalasin E and K, the genome of A. clavatus was analyzed and the ~30 kb ccs gene cluster was identified based on the presence of a polyketide synthase-nonribosomal peptide synthetases (PKS-NRPS) and a putative Baeyer-Villiger monooxygenase (BVMO). Deletion of the central PKS-NRPS gene, ccsA, abolished the production of cytochalasin E and K, confirming the association between the natural products and the gene cluster. Based on bioinformatic analysis, a putative biosynthetic pathway is proposed. Furthermore, overexpression of the pathway specific regulator ccsR elevated the titer of cytochalasin E from 25 mg/L to 175 mg/L. Our results not only shed light on the biosynthesis of cytochalasins, but also provided genetic tools for increasing and engineering the production
Formation and Properties of 1-D Alumina Nanostructures Prepared via a Template-free Thermal Reaction
AbstractA facile template-free thermal reaction was applied to prepare one dimensional (1-D) alumina nanostructures. Through utilizing the anisotropic modules existing in layered structures, the 1-D alumina nanostructures could be controlled to form nanotubes or nanorods with various configuration. The characters were then carefully studied and discussed based on the observation of TEM, XRD and photoluminescence
Investigation of Fungal Iterative Polyketide Synthase Functions Using Partially Assembled Intermediates
Iterative polyketide synthases (PKSs) are large, multifunctional
enzymes that resemble eukaryotic fatty acid synthases but can make
highly functionalized secondary metabolites using complex and unresolved
programming rules. During biosynthesis of the kinase inhibitor hypothemycin
by Hypomyces subiculosus, a highly
reducing iterative PKS, Hpm8, cooperates with a nonreducing iterative
PKS, Hpm3, to construct the advanced intermediate dehydrozearalenol
(DHZ). The identity of putative intermediates in the formation of
the highly reduced hexaketide portion of DHZ were confirmed by incorporation
of <sup>13</sup>C-labeled <i>N</i>-acetylcysteamine (SNAC)
thioesters using the purified enzymes. The results show that Hpm8
can accept SNAC thioesters of intermediates that are ready for transfer
from its acyl carrier protein domain to its ketosynthase domain and
assemble them into DHZ in cooperation with Hpm3. Addition of certain
structurally modified analogues of intermediates to Hpm8 and Hpm3
can produce DHZ derivatives
Recommended from our members
A carbonate-forming Baeyer-Villiger monooxygenase.
Despite the remarkable versatility displayed by flavin-dependent monooxygenases (FMOs) in natural product biosynthesis, one notably missing activity is the oxidative generation of carbonate functional groups. We describe a multifunctional Baeyer-Villiger monooxygenase, CcsB, which catalyzes the formation of an in-line carbonate in the macrocyclic portion of cytochalasin E. This study expands the repertoire of activities of FMOs and provides a possible synthetic strategy for transformation of ketones into carbonates
Gene variations in Autism Spectrum Disorder are associated with alternation of gut microbiota, metabolites and cytokines
The genetic variations and dysbiosis of gut microbiota are associated with ASD. However, the role of the microbiota in the etiology of ASD in terms of host genetic susceptibility remains unclear. This study aims to systematically explore the interplay between host genetic variation and gut microbiota in ASD children. Whole-exon sequencing was applied to 26 ASD children and 26 matched controls to identify the single nucleotide variations (SNVs) in ASD. Our previous study revealed alteration in gut microbiota and disorder of metabolism activity in ASD for this cohort. Systematic bioinformatic analyses were further performed to identify associations between SNVs and gut microbiota, as well as their metabolites. The ASD SNVs were significantly enriched in genes associated with innate immune response, protein glycosylation process, and retrograde axonal transport. These SNVs were also correlated with the microbiome composition and a broad aspect of microbial functions, especially metabolism. Additionally, the abundance of metabolites involved in the metabolic network of neurotransmitters was inferred to be causally related to specific SNVs and microbes. Furthermore, our data suggested that the interaction of host genetics and gut microbes may play a crucial role in the immune and metabolism homeostasis of ASD. This study may provide valuable clues to investigate the interaction of host genetic variations and gut microbiota in the pathogenesis of ASD
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder
Autism Spectrum Disorder (ASD) is a severe neurodevelopmental disorder. To enhance the understanding of the gut microbiota structure in ASD children at different ages as well as the relationship between gut microbiota and fecal metabolites, we first used the 16S rRNA sequencing to evaluate the gut microbial population in a cohort of 143 children aged 2–13 years old. We found that the α-diversity of ASD group showed no significant change with age, while the TD group showed increased α-diversity with age, which indicates that the compositional development of the gut microbiota in ASD varies at different ages in ways that are not consistent with TD group. Recent studies have shown that chronic constipation is one of the most commonly obvious gastrointestinal (GI) symptoms along with ASD core symptoms. To further investigate the potential interaction effects between ASD and GI symptoms, the 30 C-ASD and their aged-matched TD were picked out to perform metagenomics analysis. We observed that C-ASD group displayed decreased diversity, depletion of species of Sutterella, Prevotella, and Bacteroides as well as dysregulation of associated metabolism activities, which may involve in the pathogenesis of C-ASD. Consistent with metagenomic analysis, liquid chromatography-mass spectrometry (LC/MS) revealed some of the differential metabolites between C-ASD and TD group were involved in the metabolic network of neurotransmitters including serotonin, dopamine, histidine, and GABA. Furthermore, we found these differences in metabolites were associated with altered abundance of specific bacteria. The study suggested possible future modalities for ASD intervention through targeting the specific bacteria associated with neurotransmitter metabolism